Macrolux is a Shenzhen-based medical technology company that provides endoscopic interventional diagnosis and treatment solutions. Its products serve departments including urology, respiration and digestion and are developed using an innovation-driven engine. Founded in October 2020 and led by General Manager Zhang Weiqiang, the company aims to detect diseases earlier and offer patients better treatments. Macrolux recently closed nearly CNY100M in a Series A funding round led by Legend Capital. The company intends to use the funds to accelerate growth, expand operations and broaden its business reach.

Total raised

$15M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2023